FOSUN 复星

S&P Global Ratings has assigned ‘A’ long-term Issuer Credit and Financial Strength Ratings, with a stable outlook, to Fidelidade – Companhia de Seguros, S.A. and its reinsurer, Fidelidade RE. S&P Global expects Fidelidade to maintain strong capital, solid profitability, and market leadership both in Portugal and internationally over the next two years. This is Fidelidade’s second ‘A’ rating in a short period. In September 2024, Fitch Ratings upgraded Fidelidade to A+ (IFS) and A (IDR), both with a Stable Outlook — the highest rating ever given by Fitch to a Portuguese company at the time. https://lnkd.in/e4Df3Stb

Shanghai Henlius, founded in 2010 by Fosun Pharma, has grown from a #biotech startup into a profitable cancer drug maker. Speaking to Forbes China, CEO Jason Zhu credits this to balancing low-risk biosimilars with high-reward innovations like antibody-drug conjugates. Looking ahead, Henlius plans to deepen its globalization strategy, shifting from out-licensing to self-marketing, while increasing its international commercial and R&D investments. Mr Zhu believes that despite geopolitical tensions, the universality of diseases like #cancer ensures continued global demand for high-quality and affordable treatments. https://lnkd.in/dza58iaj

The 2025 Thailand Yuyuan Lantern Festival was officially illuminated at #ICONSIAM, a renowned commercial landmark in #Bangkok on the 28th June. The #LanternFestival continues the theme of traditional Chinese culture, inspired by "The Classic of Mountains and Seas", while incorporating local Thai elements into its design. Leveraging ICONSIAM’s unique location beside the Chao Phraya River, the festival features themed lantern installations that create a riverside spectacle of light and shadow. This large-scale outdoor immersive experience is both mysterious and vibrant, capturing a lively, festive atmosphere. The 50-day festival, which runs until 15th August, is also a special event to mark the 50th anniversary of diplomatic relations between China and Thailand. The #Yuyuan Lantern Festival, organised and hosted by Fosun's Yuyuan Inc., is China’s longest running lantern show, having been held consecutively for 30 years. In December 2023, it staged its first overseas edition in Paris, attracting 200,000 local visitors.

Henlius’ self-developed anti-PD-1 monoclonal antibody #serplulimab (marketed in Europe as Hetronifly®) has been approved in both the United Kingdom and India for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC). Commercialization in the UK and India will be led by Henlius’ partner Intas Pharmaceuticals and its subsidiary Accord Healthcare. Lung #cancer remains the leading cause of cancer-related deaths worldwide. Serplulimab is the first anti-PD-1 monoclonal antibody globally approved for the first-line treatment of ES-SCLC and has already benefited over 110,000 patients. For more details: https://lnkd.in/d8UhqA-i

2025 Fosun Hi-Po Partners Make Their Official Debut! On June 21, the inaugural Fosun Hi-Po Partner Certification Ceremony was successfully held — connecting over 40 young talents from across the globe, both online and offline. In this solemn and inspiring moment, our Hi-Po Partners made bold pledges to carry out Fosun's strategy and drive innovation forward. This marks a key milestone of Fosun's talent strategy. Combining vision with action, our Hi-Po Partners are ready to grow, lead, and shine. Let's cheer them on as they begin this exciting journey of growth and impact! #FosunHipoPartner #FosunTalent

Fosun Tourism Group is one of the four core subsidiaries of Fosun International. In recent years, Fosun Tourism Group has been diving deep into #ski tourism, aiming to redefine the winter sports experience. The recent groundbreaking of Phase II of the Taicang Alps Resort marks a major milestone—set to become the world’s largest indoor ski resort, it is poised to break five world records, including those for the longest indoor ski slope and the greatest vertical drop. Discover more about this exciting journey in this edition of  #FosunInsights. #tourism

At the 2025 American Society of Clinical Oncology (ASCO) Meeting — one of the most influential global conference in oncology — Fosun Pharma presented nearly 20 leading research studies, underscoring its progress in #cancer treatment and clinical innovation. With deep roots in China and a steadily expanding global presence, Fosun Pharma has brought its innovative therapies to over 50 countries and regions. This reflects its evolution from developing new drugs domestically to a broader role in contributing global cancer care. Explore Fosun Pharma's journey of innovation and breakthroughs in this edition of #FosunInsights. #biologics #biopharmaceuticals

Fosun International Limited (HKEX stock code: 00656) was recently notified by the renowned British finance magazine,Global Banking and Finance Review,that it has received three awards: “ESG & Sustainability Awards–Best Sustainable Development Company Asia 2025”, “CSR Awards–Best CSR Company Asia 2025”, and “Brand of the Year Awards–Holding Group Brand of the Year Asia 2025”. These accolades underscore the market’s recognition of Fosun’s exceptional performance in ESG strategy, corporate governance, social responsibility, environmental protection, information disclosure, and stakeholder engagement. Looking back on the past, Fosun has always paid attention to the reform and development of the global policies in the field of sustainable development. It has established a comprehensive ESG management system, integrated ESG management requirements into business management over the years, actively responded to national and global strategies in relation to sustainable development, ensured information security, promoted technology innovation, implemented “dual carbon” goals, protected the rights and interests of employees to promote sustainable management and value creation. #FosunESG #CreateIMPACT

Construction has officially begun on the second phase of what will become the world’s largest indoor ski resort, located in #Taicang — a city just 50 kilometers from downtown #Shanghai. With a total investment of approximately 5 billion yuan, the project is being developed by a platform backed by the Taicang municipal government in partnership with Fosun Tourism Group, the flagship tourism arm of Fosun International. Phase II is scheduled for completion and public opening by June 2029. Once completed, the second phase will break several world records for indoor ski facilities, including a 650-meter-long slope and a 100-meter vertical drop. Combined with the existing Phase I facilities, the resort will feature the world’s longest indoor ski trail at 1,777 meters and the largest cold-zone area, spanning over 100,000 square meters. The development also includes two internationally themed hotels and six major entertainment attractions. Since its official opening in October 2023, Phase I of the Taicang Alps International Resort has welcomed more than 1 million visitors. #SkiResort #FosunTourismGroup #tourism For more details, here's the report by Yicai 第一财经 https://lnkd.in/eJqbfath

Protechting 7.0 China Roadshow Wraps Up with a Bang! The top four teams hit the stage in Shanghai, Macau, Shenzhen, and Hong Kong, showcasing their projects and sharing their visions. Along the way, they joined the 5th BEYOND Expo in Macau, engaging with leading innovators and investors across the Greater Bay Area — and experiencing China's speed and tech power firsthand. Over the past eight years, Protechting has become a key platform connecting young innovators from China and around the world. We remain committed to bringing together diverse resources and encouraging the next generation of global entrepreneurs to turn their ideas into reality. As we continue to foster cross-border collaboration and cultural exchange, we look forward to writing the next chapter—together. #Protechting #InnovationWithoutBorders #FosunInnovation #GlobalYouth